Is Imax Losing Its Edge In A Changing Movie Industry? Piper Jaffray Downgrades On Multiple Stock Pressures
While Imax Corp (USA) (NYSE: IMAX) may have had some differentiating advantages that gave it a competitive edge in a changing movie business, this may no longer be the case, according to Piper Jaffray.
The Analyst
Piper Jaffray's Stan Meyers downgraded Imax's stock rating from Overweight to Neutral with a price target slashed from $28 to $21.
The Thesis
Imax faces pressure on six different fronts that drove Piper Jaffray's downgrade, Meyers said in a research report. (See the analyst's track record here.)
They are:
- Expectations for "major estimate revisions" for Imax's fourth quarter to the downside.
- The ongoing loss of casual fans of Imax's offerings.
- Continued declines in per-screen averages in China.
- A lack of new initiatives like virtual reality.
- The absence of an upgrade option on MoviePass for Imax.
- Expectations for a meaningful deceleration in the top line.
Looking forward to the full year 2018, Meyers said he sees "limited" box office growth despite a film slate loaded with Imax-friendly films. The company is now expected to earn 88 cents per share in fiscal 2018 on revenue of $360.1 million versus the analyst's prior estimate of $1.18 per share on revenue of $400.7 million. The Street's estimate stands at 95 cents per share on revenue of $404.6 million.
Price Action
Shares of Imax were trading flat at $20.45 late in Wednesday's trading session.
Should You Get Rid Of Imax Corporation Now?
3 Reasons To Own IMAX Shares For The Long Term
Latest Ratings for IMAX
Date | Firm | Action | From | To |
---|---|---|---|---|
Oct 2021 | Wells Fargo | Initiates Coverage On | Overweight | |
Jun 2021 | Goldman Sachs | Downgrades | Neutral | Sell |
Apr 2021 | Wedbush | Upgrades | Neutral | Outperform |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: imax Imax China movies Piper Jaffray Stan MeyersAnalyst Color Analyst Ratings Best of Benzinga